Results 161 to 170 of about 3,661,902 (238)

Peripartum cardiomyopathy in an intensive care unit setting. [PDF]

open access: yesWorld J Crit Care Med
Zaidi SF   +7 more
europepmc   +1 more source

Differences between Current Clinical Practice and Evidence-Based Guideline Recommendations Regarding Tocolysis - an Austria-wide Survey.

open access: yesGeburtshilfe Frauenheilkd
Enengl S   +8 more
europepmc   +1 more source

KV7 channel activation inhibits human and murine myometrium contractility and delays delivery in a mouse model of preterm birth

open access: yes
Tribe R   +14 more
europepmc   +1 more source

Pharmacokinetics of Tocolytic Agents

Clinical Pharmacokinetics, 2004
Tocolytic agents are drugs designed to inhibit contractions of myometrial smooth muscle cells. Such an effect has been demonstrated in vitro or in vivo for several pharmacological agents, including beta-adrenergic agonists, calcium channel antagonists, oxytocin antagonists, NSAIDs and magnesium sulfate. However, the aim of tocolysis is not only to stop
Vassilis, Tsatsaris   +2 more
openaire   +3 more sources

Prevention and Tocolytic Agents 2

Preterm Labor and Delivery, 2019
Preterm birth is the single most important determinant of adverse infant outcomes, in terms of survival and quality of life. Preterm infants are particularly vulnerable to complications with the increasing contribution of neonatal deaths to overall child mortality.
M. Ohashi
openaire   +2 more sources

Prostaglandin inhibitors as tocolytic agents

Seminars in Perinatology, 2001
Indomethacin, a nonspecific prostaglandin synthetase inhibitor, gained popularity several decades ago as a potent tocolytic agent. This popularity, however, was tempered by concerns over fetal and neonatal complications associated with its use. However, with better recognition of the safety limitations, there has been a renewed interest in using ...
S T, Vermillion, C N, Landen
openaire   +3 more sources

Home - About - Disclaimer - Privacy